1426 - 1450 of 6433 Results
Title
Year
-
OPENTitle: Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domainsJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 10Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/trc2.12461Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/trc2.12461Citation Count: 23
-
OPENTitle: Why Therapeutic Trials Fail in Primary TauopathiesJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 4Start Page: 545End Page: 550Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29322Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10398638/pdf/nihms-1915318.pdfCitation Count: 5
-
OPENTitle: Duodenal alpha‐Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 885End Page: 894Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29358Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29358Citation Count: 34
-
OPENTitle: Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 4Start Page: 706End Page: 714Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29725Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29725Citation Count: 8
-
OPENTitle: Presenilin‐1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stageJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 4Start Page: 2680End Page: 2697Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/alz.13729Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13729Citation Count: 5
-
OPENTitle: Levodopa Impairs the Energy Metabolism of the Basal Ganglia In VivoJournal Name: Annals of NeurologyPublisher: WileyVol: 95Issue #: 5Start Page: 849End Page: 857Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26884Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26884Citation Count: 11
-
OPENTitle: Neuronal dysfunction and gene modulation by non-coding RNA in Parkinson’s disease and synucleinopathiesJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fncel.2023.1328269Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2023.1328269/pdf?isPublishedV2=FalseCitation Count: 8
-
OPENTitle: PICALO: principal interaction component analysis for the identification of discrete technical, cell-type, and environmental factors that mediate eQTLsJournal Name: Genome BiologyPublisher: Springer Science and Business Media LLCVol: 25Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13059-023-03151-0Best OA location URL: https://genomebiology.biomedcentral.com/counter/pdf/10.1186/s13059-023-03151-0Citation Count: 3
-
OPENTitle: Reduced progranulin increases tau and α-synuclein inclusions and alters mouse tauopathy phenotypes via glucocerebrosidaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-45692-3Best OA location URL: https://www.nature.com/articles/s41467-024-45692-3.pdfCitation Count: 14
-
OPENTitle: Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-46832-5Best OA location URL: https://www.nature.com/articles/s41467-024-46832-5.pdfCitation Count: 40
-
OPENTitle: RASP: Optimal Single Puncta Detection in Complex Cellular BackgroundsJournal Name: The Journal of Physical Chemistry BPublisher: American Chemical Society (ACS)Vol: 128Issue #: 15Start Page: 3585End Page: 3597Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.jpcb.4c00174Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jpcb.4c00174Citation Count: 3
- Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease Risk (4286)2021OPENTitle: Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease Risk (4286)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 96Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.96.15_supplement.4286Citation Count: 3
-
OPENTitle: Erythroid Differentiation Dependent Interaction of VPS13A with XK at the Plasma Membrane of K562 CellsJournal Name: ContactPublisher: SAGE PublicationsVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1177/25152564231215133Best OA location URL: https://doi.org/10.1177/25152564231215133Citation Count: 9
- Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregation2023OPENTitle: Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 46Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adi8716Best OA location URL: https://doi.org/10.1126/sciadv.adi8716Citation Count: 106
-
OPENTitle: Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structuresJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 48Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adk6191Best OA location URL: https://doi.org/10.1126/sciadv.adk6191Citation Count: 27
- LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversification2023OPENTitle: LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversificationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 44Start Page: eadh9543End Page: eadh9543Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adh9543Best OA location URL: https://doi.org/10.1126/sciadv.adh9543Citation Count: 54
-
OPENTitle: α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an in vitro proof of concept studyJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 5Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcad285Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcad285/52454987/fcad285.pdfCitation Count: 10
-
OPENTitle: Prediction of dyskinesia in Parkinson’s disease patients using machine learning algorithmsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-49617-wBest OA location URL: https://www.nature.com/articles/s41598-023-49617-w.pdfCitation Count: 2
-
OPENTitle: Fas gene dosage tunes the extent of lymphoproliferation and T cell differentiation in lupusJournal Name: Clinical ImmunologyPublisher: Elsevier BVVol: 258Issue #:Start Page: 109874End Page: 109874Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.clim.2023.109874Best OA location URL: https://doi.org/10.1016/j.clim.2023.109874Citation Count: 0
-
OPENTitle: Predicting cognitive decline in a low‐dimensional representation of brain morphologyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: S10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.081611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.081611Citation Count: 0
-
OPENTitle: Exploratory correlation of the human structural connectome with non‐MRI variables in Alzheimer's diseaseJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 15Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/dad2.12511Best OA location URL: https://doi.org/10.1002/dad2.12511Citation Count: 6
- Constructing treatment episodes from concomitant medication logs: a prospective observational study2020OPENTitle: Constructing treatment episodes from concomitant medication logs: a prospective observational studyJournal Name: BMJ OpenPublisher: BMJVol: 10Issue #: 3Start Page: e034305End Page: e034305Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2019-034305Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/10/3/e034305.full.pdfCitation Count: 4
- Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?2023OPENTitle: Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?Journal Name: Environment InternationalPublisher: Elsevier BVVol: 173Issue #:Start Page: 107852End Page: 107852Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.envint.2023.107852Best OA location URL: https://doi.org/10.1016/j.envint.2023.107852Citation Count: 1
-
OPENTitle: Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trialJournal Name: eClinicalMedicinePublisher: Elsevier BVVol: 69Issue #:Start Page: 102474End Page: 102474Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.eclinm.2024.102474Best OA location URL: http://www.thelancet.com/article/S2589537024000531/pdfCitation Count: 18
-
OPENTitle: Mitochondrial DNA deletions in the cerebrospinal fluid of patients with idiopathic REM sleep behaviour disorderJournal Name: eBioMedicinePublisher: Elsevier BVVol: 102Issue #:Start Page: 105065End Page: 105065Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.ebiom.2024.105065Best OA location URL: http://www.thelancet.com/article/S2352396424001002/pdfCitation Count: 7